Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Evolent Health, Inc. made materially false and/or misleading statements and/or failed to disclose that: On August 8, 2025, Evolent issued a press release announcing second quarter revenue results that were below analysts’ expectations. Management lowered its full-year revenue guidance attributing it to volatility in the managed care industry. Following this news, Evolent’s stock price fell by $1.30 per share to open at $8.39 per share.
In order to be eligible to join the EVH class action lawsuit, you must have incurred a loss on shares of Evolent Health, Inc. purchased during the class period listed above.
TOP
